Herpes Simplex: Insights on Pathogenesis and Possible Vaccines
about
Herpes simplex virus and varicella zoster virus, the house guests who never leaveTowards a rational design of an asymptomatic clinical herpes vaccine: the old, the new, and the unknownInfectious co-factors in HIV-1 transmission herpes simplex virus type-2 and HIV-1: new insights and interventionsThe role of dendritic cells in immunity against primary herpes simplex virus infectionsThe molecular basis of herpes simplex virus latencyStudying the immune response to human viral infections using zebrafishAxonal spread of neuroinvasive viral infectionsA macaque model to study vaginal HSV-2/immunodeficiency virus co-infection and the impact of HSV-2 on microbicide efficacyDetection of human herpesvirus-6 in cerebrospinal fluid of patients with encephalitisA review study on the effect of Iranian herbal medicines against in vitro replication of herpes simplex virusThe Sordid Affair Between Human Herpesvirus and HIVImmune Regulation of Antibody Access to Neuronal TissuesThe C terminus of the large tegument protein pUL36 contains multiple capsid binding sites that function differently during assembly and cell entry of herpes simplex virusInterferon lambda inhibits herpes simplex virus type I infection of human astrocytes and neuronsAsymptomatic human CD4+ cytotoxic T-cell epitopes identified from herpes simplex virus glycoprotein BClinical reactivations of herpes simplex virus type 2 infection and human immunodeficiency virus disease progression markers.A herpes simplex virus 2 (HSV-2) glycoprotein D-expressing nonreplicating dominant-negative HSV-2 virus vaccine is superior to a gD2 subunit vaccine against HSV-2 genital infection in guinea pigsRegulation of herpes simplex virus type 1 thymidine kinase gene expression by thyroid hormone receptor in cultured neuronal cells.An attenuated herpes simplex virus type 1 (HSV1) encoding the HIV-1 Tat protein protects mice from a deadly mucosal HSV1 challengePassively administered pooled human immunoglobulins exert IL-10 dependent anti-inflammatory effects that protect against fatal HSV encephalitis.A wide extent of inter-strain diversity in virulent and vaccine strains of alphaherpesviruses.Prophylactic and therapeutic modulation of innate and adaptive immunity against mucosal infection of herpes simplex virusHerpes simplex virus type 2 triggers reactivation of Kaposi's sarcoma-associated herpesvirus from latency and collaborates with HIV-1 Tat.Pan-HSV-2 IgG antibody in vaccinated mice and guinea pigs correlates with protection against herpes simplex virus 2.Recruited inflammatory monocytes stimulate antiviral Th1 immunity in infected tissue.Intravaginal Zinc Oxide Tetrapod Nanoparticles as Novel Immunoprotective Agents against Genital Herpes.Vaginal memory T cells induced by intranasal vaccination are critical for protective T cell recruitment and prevention of genital HSV-2 disease.Genome-wide prediction of vaccine targets for human herpes simplex viruses using Vaxign reverse vaccinologyAutophagy in herpesvirus immune control and immune escape.Immunization with herpes simplex virus 2 (HSV-2) genes plus inactivated HSV-2 is highly protective against acute and recurrent HSV-2 diseaseEffects of herpes simplex virus type 2 glycoprotein vaccines and CLDC adjuvant on genital herpes infection in the guinea pig.SOCS1/3 expression levels in HSV-1-infected, cytokine-polarized and -unpolarized macrophagesTopical herpes simplex virus 2 (HSV-2) vaccination with human papillomavirus vectors expressing gB/gD ectodomains induces genital-tissue-resident memory CD8+ T cells and reduces genital disease and viral shedding after HSV-2 challengeA novel DNA vaccine technology conveying protection against a lethal herpes simplex viral challenge in miceDevelopment of a glycoprotein D-expressing dominant-negative and replication-defective herpes simplex virus 2 (HSV-2) recombinant viral vaccine against HSV-2 infection in miceStability of glycoprotein gene sequences of herpes simplex virus type 2 from primary to recurrent human infection, and diversity of the sequences among patients attending an STD clinic.Cervico-vaginal tissue ex vivo as a model to study early events in HIV-1 infection.Innate lymphotoxin receptor mediated signaling promotes HSV-1 associated neuroinflammation and viral replication.The Role of Plasmacytoid Dendritic Cells in Innate and Adaptive Immune Responses against Alpha Herpes Virus InfectionsCross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine.
P2860
Q21195896-FA1F1E48-B859-4340-84EC-341D7E46D2A4Q21296712-004995D8-FEF5-4795-A6A4-0286C895D528Q26823594-A2A1091A-C454-4700-969E-4C3D4D9BAF94Q26827217-1C8E4448-064D-41EE-A1E1-7CB6E0AF1226Q27001272-D3301BAA-875F-40A4-A336-F4B9AB44EE1DQ27002635-4909279C-E681-42D4-A518-52E6315F0C9DQ27025965-28D4DC8C-8C7E-4BEA-B7D7-E715D8ADC482Q27335068-0F0AE0FA-60F5-4E0C-924E-618F06D0B284Q27488291-A8C25402-F736-4DAF-8D5E-B43FB38E005CQ28077334-7A3C2727-A82F-426A-97CF-C714CC30D14BQ28083192-F71AD38B-68BF-4384-8BE7-ED48478023D4Q28733365-05A5A3B7-034C-42F6-AFBF-C01F9CC5E7BCQ30424771-27C30AA1-BDF3-4430-9B34-2DA7BCD4CA07Q30499869-2952621E-175C-4872-850C-4885A7C9B039Q30847945-6F2BF458-9DA5-4BDD-ABB7-BD6CF8FEF7E9Q33550768-7F362870-27DE-43D2-BBCB-8ED8833B393CQ33825931-9BDFF9BA-06F8-4A31-AB12-7F7519035FC7Q33883878-D573EE00-D14D-4FB4-AB27-9EC1C33FCD1EQ33916162-E378666A-588E-4699-AB63-30EDAC92669DQ33926907-371936A3-5394-407E-BAF5-08F97301CF4FQ34055287-2F07A5C5-526E-4DE9-A0EC-526CB7F1D6B9Q34105712-45F78466-44CA-437E-A7C2-D7FB3E36033BQ34162920-003D6CC5-6C0F-4A14-9B67-F038DB2CC8E6Q34350019-90B96786-7CCD-4AE0-B60C-8B92F9A7C574Q34471984-E2D75726-38D3-4D4C-8F39-486E19DD1A70Q34526716-2FEC35B5-BF30-4836-9F48-6B8DA0A67627Q34594102-E3DA42DA-57AD-4728-971E-702E60A8F8F8Q34628398-81B5A6D0-90A1-4E8C-9B6A-6A6DB87C8B91Q34712746-D198114C-9BB6-4D4C-9B0B-0F25F71D6798Q34742583-140B4811-9E9E-4C10-89A0-94652F0BC168Q34856138-7E148AD0-F394-41E2-8B16-24501640084DQ34920297-5A2A549C-AE8C-4EE5-8CC5-B49F9AA746AFQ34992660-F25D2FAC-EA28-41FA-B96B-9D0C9F2603ACQ35009410-1CDB03C9-446F-4568-86DD-135437BF9C61Q35076638-06FF8008-F7A8-43AE-BC88-5B4B295B4813Q35087406-A5D0A999-49A2-466A-B8E4-C1E111512475Q35252587-0DDB3036-EE22-4578-BDBC-258C7022FD61Q35627416-501A0100-9E83-4607-8425-1C97963B9B94Q35692343-8190A610-B6FB-4A60-A40F-2953AD1B3BFFQ35699002-949D5BE7-C460-41C6-80B4-E5E497F3F43F
P2860
Herpes Simplex: Insights on Pathogenesis and Possible Vaccines
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Herpes Simplex: Insights on Pathogenesis and Possible Vaccines
@ast
Herpes Simplex: Insights on Pathogenesis and Possible Vaccines
@en
Herpes Simplex: Insights on Pathogenesis and Possible Vaccines
@en-gb
Herpes Simplex: Insights on Pathogenesis and Possible Vaccines
@nl
type
label
Herpes Simplex: Insights on Pathogenesis and Possible Vaccines
@ast
Herpes Simplex: Insights on Pathogenesis and Possible Vaccines
@en
Herpes Simplex: Insights on Pathogenesis and Possible Vaccines
@en-gb
Herpes Simplex: Insights on Pathogenesis and Possible Vaccines
@nl
altLabel
Herpes simplex: insights on pathogenesis and possible vaccines
@en
prefLabel
Herpes Simplex: Insights on Pathogenesis and Possible Vaccines
@ast
Herpes Simplex: Insights on Pathogenesis and Possible Vaccines
@en
Herpes Simplex: Insights on Pathogenesis and Possible Vaccines
@en-gb
Herpes Simplex: Insights on Pathogenesis and Possible Vaccines
@nl
P3181
P1476
Herpes Simplex: Insights on Pathogenesis and Possible Vaccines
@en
P2093
David M. Koelle
P304
P3181
P356
10.1146/ANNUREV.MED.59.061606.095540
P407
P577
2008-02-01T00:00:00Z